AU2001239544A1 - Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same - Google Patents

Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same

Info

Publication number
AU2001239544A1
AU2001239544A1 AU2001239544A AU3954401A AU2001239544A1 AU 2001239544 A1 AU2001239544 A1 AU 2001239544A1 AU 2001239544 A AU2001239544 A AU 2001239544A AU 3954401 A AU3954401 A AU 3954401A AU 2001239544 A1 AU2001239544 A1 AU 2001239544A1
Authority
AU
Australia
Prior art keywords
image diagnosis
analogue
composition
same
probe based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001239544A
Inventor
Yukitsuka Kudo
Hiroshi Shimazu
Takahiro Suemoto
Masako Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BF Research Institute Inc
Original Assignee
BF Research Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BF Research Institute Inc filed Critical BF Research Institute Inc
Publication of AU2001239544A1 publication Critical patent/AU2001239544A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0497Organic compounds conjugates with a carrier being an organic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/49Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring having at least two amino groups bound to the carbon skeleton
    • C07C211/50Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring having at least two amino groups bound to the carbon skeleton with at least two amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C245/00Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
    • C07C245/02Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides
    • C07C245/06Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings
    • C07C245/08Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings with the two nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings, e.g. azobenzene
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/20Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups being part of rings other than six-membered aromatic rings
    • C07C251/22Quinone imines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/24Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/28Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/45Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/46Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton having the sulfo groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/28Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/45Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/47Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton having at least one of the sulfo groups bound to a carbon atom of a six-membered aromatic ring being part of a condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/78Halides of sulfonic acids
    • C07C309/86Halides of sulfonic acids having halosulfonyl groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/88Halides of sulfonic acids having halosulfonyl groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/31Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/33Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to a carbon atom of the same non-condensed six-membered aromatic ring
    • C07C323/35Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to a carbon atom of the same non-condensed six-membered aromatic ring the thio group being a sulfide group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/31Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/38Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with the sulfur atom of the thio group bound to a carbon atom of a six-membered aromatic ring being part of a condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C331/00Derivatives of thiocyanic acid or of isothiocyanic acid
    • C07C331/16Isothiocyanates
    • C07C331/28Isothiocyanates having isothiocyanate groups bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001239544A 2000-03-22 2001-03-21 Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same Abandoned AU2001239544A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000080081 2000-03-22
JP2000-80081 2000-03-22
PCT/JP2001/002204 WO2001070667A1 (en) 2000-03-22 2001-03-21 Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same

Publications (1)

Publication Number Publication Date
AU2001239544A1 true AU2001239544A1 (en) 2001-10-03

Family

ID=18597236

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001239544A Abandoned AU2001239544A1 (en) 2000-03-22 2001-03-21 Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same

Country Status (4)

Country Link
US (1) US20030138374A1 (en)
EP (1) EP1266884A4 (en)
AU (1) AU2001239544A1 (en)
WO (1) WO2001070667A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2004054978A1 (en) * 2002-12-16 2006-04-20 株式会社 ビーエフ研究所 Quinoline derivatives as diagnostic probes for tau protein storage diseases
AU2004218452A1 (en) * 2003-03-03 2004-09-16 Mycosol, Inc. Pyridinium salts, compounds and methods of use
US20050118226A1 (en) * 2003-11-07 2005-06-02 Kovacs Dora M. Methods for treating ACAT-related diseases
EP1630205A1 (en) * 2004-08-24 2006-03-01 Clariant International Ltd. New styrylpyridinium imine based dyes and their use in optical layers for optical data recording
CN100358582C (en) * 2005-03-25 2008-01-02 北京师范大学 Early senile dementia alpha beta starch spot imaging agent
US20120237446A1 (en) * 2005-03-25 2012-09-20 Bayer Pharma Aktiengesellschaft Compounds for binding and imaging amyloid plaques and their use
US20090185975A1 (en) * 2005-12-26 2009-07-23 Tohoku University Diagnostic probe for conformation disease
US7687052B2 (en) * 2006-03-30 2010-03-30 The Trustees Of The University Of Pennsylvania Styrylpyridine derivatives and their use for binding and imaging amyloid plaques
EP2103611A4 (en) * 2006-12-25 2010-06-30 Univ Tohoku Benzoxazole derivatives
US20100272642A1 (en) * 2007-07-04 2010-10-28 Tohoku University Pet probe having an alkoxy group substituted by fluorine and hydroxy group
EP2368558A1 (en) 2010-03-23 2011-09-28 Mdc Max-Delbrück-Centrum Für Molekulare Medizin Berlin - Buch Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates
CN102557969B (en) * 2011-11-01 2015-03-18 中国科学技术大学 Cyclic ketone derivatives and applications thereof as developers and aggregation inhibitors of amyloid protein sediments and neurofibrillary tangles
US20170176469A1 (en) * 2012-02-24 2017-06-22 Case Western Reserve University Molecular Probes for Detecting Lipids
US9180212B2 (en) * 2012-05-22 2015-11-10 The Regents Of The University Of California β-amyloid plaque imaging agents
CN104151193B (en) * 2014-07-10 2016-01-20 广西华锡集团股份有限公司 (methylene imine base-(4-styryl-tribenzylamine)) phenol photosensitizers and synthetic method thereof
CN112525868B (en) * 2019-09-19 2022-04-22 吉林大学 Application of quinaldine red and derivatives thereof in preparation of kit for detecting amyloid fibers

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3085935A (en) * 1961-04-24 1963-04-16 Burroughs Wellcome Co Method for the elimination of nematode infestations
DE3563611D1 (en) * 1984-03-06 1988-08-11 Mitsubishi Chem Ind Method for the partial hydrogenation of conjugated dienes
CA1323949C (en) * 1987-04-02 1993-11-02 Michael C. Palazzotto Ternary photoinitiator system for addition polymerization
EP0287909B1 (en) * 1987-04-08 1992-09-02 Salutar, Inc. Amyloidosis and alzheimer's disease diagnostic assay and reagents therefor
DE69010537T2 (en) * 1989-04-01 1994-12-01 Nippon Sheet Glass Co Ltd Process for producing a layered material with an organic dye-containing silicon dioxide film and the product thus produced.
US6417178B1 (en) * 1994-07-19 2002-07-09 University Of Pittsburgh Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits
WO1997016194A1 (en) * 1995-11-02 1997-05-09 Warner-Lambert Company Naphthylazo inhibition of amyloidosis
WO1997026919A2 (en) * 1996-01-24 1997-07-31 Warner-Lambert Company Method of imaging amyloid deposits
US5958919A (en) * 1996-09-20 1999-09-28 Washington University Treatment of presymptomatic alzheimer's disease to prevent neuronal degeneration
AU748768B2 (en) * 1997-03-11 2002-06-13 General Hospital Corporation, The Identification of agents for use in the treatment of Alzheimer's disease
JP2000281591A (en) * 1999-03-26 2000-10-10 Bf Kenkyusho:Kk Image diagnostic probe for amyloid-accumulating disease with basic blue-41 and palatine fast black wan and image diagnostic composition containing the same
NZ515621A (en) * 1999-06-10 2004-05-28 Warner Lambert Co Medicaments for inhibiting amyloid protein aggregation and methods of imaging amyloid deposits
ES2536449T3 (en) * 2000-08-24 2015-05-25 University Of Pittsburgh Of The Commonwealth System Of Higher Education Thioflavin derivatives for use in the diagnosis of Alzheimer's disease

Also Published As

Publication number Publication date
US20030138374A1 (en) 2003-07-24
WO2001070667A1 (en) 2001-09-27
EP1266884A4 (en) 2003-04-23
EP1266884A1 (en) 2002-12-18

Similar Documents

Publication Publication Date Title
AU2001239544A1 (en) Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same
AU2001246803A1 (en) An image sensor and an endoscope using the same
PL348226A1 (en) Compounds for the antemortem diagnosis of alzheimer's disease and in vivo
HK1146725A1 (en) Thioflavin derivatives for use in the diagnosis of alzheimers disease
AU3891499A (en) Diagnostic tests for alzheimer's disease
DE60009923D1 (en) POSITIVE WORKING PHOTORESIST COMPOSITION AND IMAGE RECORDING ELEMENT
GB2360843B (en) Imaging probe
DE69925262D1 (en) PHARMACEUTICALS FOR THE IMAGING OF ANGIOGENIC DISEASES
SG78412A1 (en) Oxime derivatives and the use thereof as latent acids
AU2003267091A1 (en) Optical coherence tomography probe
AU6340899A (en) Oxime derivatives and the use thereof as latent acids
AU2610901A (en) Predictive diagnostic for alzheimer's disease
AU2001261728A1 (en) Use of small molecule radioligands for diagnostic imaging
AU5459000A (en) Highly sensitive biological agent probe
EE200300216A (en) Radiopharmaceuticals for the diagnosis of Alzheimer's disease
DE10084189T1 (en) Imaging unit for endoscopes
DE60127047D1 (en) Capteur d'image à l'etat solid comprenant of the photodiodes commandees porte et methode de fabrication
HUP9900426A3 (en) Amyloid binding azoderivatives, preparation thereof and use of these compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
IL156262A0 (en) Anti-cd28 antibodies having no mitogenic activity and pharmaceutical compositions containing the same
AU2001257406A1 (en) Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941
DE50109614D1 (en) MR image reconstruction
EE200100051A (en) Use of (+) - norcisapride or a pharmaceutically acceptable salt thereof substantially free of the corresponding (-) - stereoisomer and pharmaceutical composition
DE60005080D1 (en) The image recording device
AU2001244549A1 (en) Azure a analogues useful as probes in the diagnostic imaging for diseases due toaccumulation of amyloid and compositions for diagnostic imaging containing the analogues
PL1639139T3 (en) Methods for the diagnosis and prognosis of alzheimer's disease